home All News open_in_new Read More

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full

PARIS, FRANCE, 23 October 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its performance for the year to date and the third quarter of 2024.     YTD 2024 YTD 2023 % change Q3 2024 Q3 2023 % change €m €m Actual CER1 €m €m Actual CER1 Oncology 1 829,8 […]

today 4 hours ago attach_file ?
attach_file Events
attach_file Economics
attach_file Events
attach_file Economics
attach_file Culture
attach_file Culture
attach_file ?
attach_file Economics
attach_file Politics


ID: 13763942
Add Watch Country

arrow_drop_down